163 related articles for article (PubMed ID: 17637594)
21. Overview of non-Hodgkin's lymphoma: biology, staging, and treatment.
Fisher RI
Semin Oncol; 2003 Apr; 30(2 Suppl 4):3-9. PubMed ID: 12728402
[TBL] [Abstract][Full Text] [Related]
22. Use of rituximab in combination with conventional chemotherapy for the treatment of non-Hodgkin's lymphoma of the head and neck.
Manolopoulos L; Gomatos IP; Leandros E; Alevizos L; Georgiou N; Giotakis J; Ferekidis E
In Vivo; 2009; 23(3):475-8. PubMed ID: 19454517
[TBL] [Abstract][Full Text] [Related]
23. Rituximab (anti-CD20 monoclonal antibody) in lymphoproliferative malignancies: Tata Memorial experience.
Biswas G; Parikh PM; Nair R; Bhagwat R; Bakshi A; Prabhash K; Vora A; Gupta S; Pai VR; Menon H; Sastry PS
J Assoc Physicians India; 2006 Jan; 54():29-33. PubMed ID: 16649735
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies in advanced B-cell lymphomas.
Ujjani C; Cheson BD
Oncology (Williston Park); 2010 Feb; 24(2):156-66. PubMed ID: 20361466
[TBL] [Abstract][Full Text] [Related]
25. Treatment approaches and nursing applications for non-Hodgkin lymphoma.
Long JM
Clin J Oncol Nurs; 2007 Feb; 11(1 Suppl):13-21. PubMed ID: 17471823
[TBL] [Abstract][Full Text] [Related]
26. A case of non-Hodgkin's lymphoma-associated pemphigus foliaceus and use of rituximab for treatment.
Prodanovic EM; Korman NJ
J Dermatolog Treat; 2008; 19(6):1-3. PubMed ID: 18720187
[TBL] [Abstract][Full Text] [Related]
27. [Current therapeutic advances in the treatment of non-Hodgkin lymphoma].
Hernández-Rivera G; Aguayo-González A; Cano-Castellanos R; Loarca-Piña LM
Gac Med Mex; 2008; 144(3):275-7. PubMed ID: 18714599
[TBL] [Abstract][Full Text] [Related]
28. Pretargeted radioimmunotherapy for B-cell lymphomas.
Green DJ; Pagel JM; Pantelias A; Hedin N; Lin Y; Wilbur DS; Gopal A; Hamlin DK; Press OW
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5598s-5603s. PubMed ID: 17875795
[TBL] [Abstract][Full Text] [Related]
29. Rituximab: a B-cell depletion therapy for dermatologic disease.
Prajapati V; Mydlarski PR
Skin Therapy Lett; 2007; 12(6):6-9. PubMed ID: 17762903
[TBL] [Abstract][Full Text] [Related]
30. Six of 12 relapsed or refractory indolent lymphoma patients treated 10 years ago with 131I-tositumomab remain in complete remission.
Buchegger F; Antonescu C; Helg C; Kosinski M; Prior JO; Delaloye AB; Press OW; Ketterer N
J Nucl Med; 2011 Jun; 52(6):896-900. PubMed ID: 21571800
[TBL] [Abstract][Full Text] [Related]
31. Radioimmunotherapy: potential as a therapeutic strategy in non-Hodgkin's lymphoma.
Wun T; Kwon DS; Tuscano JM
BioDrugs; 2001; 15(3):151-62. PubMed ID: 11437681
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy of Non-Hodgkin's lymphomas.
Press OW; Leonard JP; Coiffier B; Levy R; Timmerman J
Hematology Am Soc Hematol Educ Program; 2001; ():221-40. PubMed ID: 11722986
[TBL] [Abstract][Full Text] [Related]
33. Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects.
Ratanatharathorn V; Pavletic S; Uberti JP
Cancer Treat Rev; 2009 Dec; 35(8):653-61. PubMed ID: 19682801
[TBL] [Abstract][Full Text] [Related]
34. Rituximab in indolent lymphomas.
Sousou T; Friedberg J
Semin Hematol; 2010 Apr; 47(2):133-42. PubMed ID: 20350660
[TBL] [Abstract][Full Text] [Related]
35. The role of complement in the mechanism of action of rituximab for B-cell lymphoma: implications for therapy.
Zhou X; Hu W; Qin X
Oncologist; 2008 Sep; 13(9):954-66. PubMed ID: 18779537
[TBL] [Abstract][Full Text] [Related]
36. Inroads in the therapy of indolent lymphomas: exploiting biological insights.
McLaughlin P
Cancer Invest; 1999; 17(1):73-86. PubMed ID: 10999051
[No Abstract] [Full Text] [Related]
37. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
Sharkey RM; Karacay H; Johnson CR; Litwin S; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
J Nucl Med; 2009 Mar; 50(3):444-53. PubMed ID: 19223402
[TBL] [Abstract][Full Text] [Related]
38. The status of radioimmunotherapy in CD20+ non-Hodgkin's lymphoma.
Read ED; Eu P; Little PJ; Piva TJ
Target Oncol; 2015 Mar; 10(1):15-26. PubMed ID: 24870968
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in the understanding and management of diffuse large B-cell lymphoma in children.
Reiter A; Klapper W
Br J Haematol; 2008 Jul; 142(3):329-47. PubMed ID: 18537979
[TBL] [Abstract][Full Text] [Related]
40. Diversity in antibody-based approaches to non-Hodgkin lymphoma.
Maloney D; Morschhauser F; Linden O; Hagenbeek A; Gisselbrecht C
Leuk Lymphoma; 2010 Aug; 51 Suppl 1():20-7. PubMed ID: 20815760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
